These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25846)

  • 21. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
    Klempt HW; Bender F
    Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
    [No Abstract]   [Full Text] [Related]  

  • 22. The dose-related effects of bolus esmolol on heart rate and blood pressure following laryngoscopy and intubation.
    Bensky KP; Donahue-Spencer L; Hertz GE; Anderson MT; James R
    AANA J; 2000 Oct; 68(5):437-42. PubMed ID: 11759128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blocking drug metipranolol: plasma levels and pharmacodynamic action in man.
    Mayer O; Cepelák V; Vitous J; Potmĕsil J
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):113-9. PubMed ID: 6103879
    [No Abstract]   [Full Text] [Related]  

  • 24. Why another beta-antagonist?
    Fitzgerald JD
    Postgrad Med J; 1977; 53 Suppl 3():52-7. PubMed ID: 22072
    [No Abstract]   [Full Text] [Related]  

  • 25. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
    O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
    Agarwal AK; Ahuja RC; Chandra M; Gupta NN; Hasan M
    J Int Med Res; 1976; 4(6):410-7. PubMed ID: 17557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopharmacological studies on the bronchoconstrictive side effect of the beta-receptor blockader talinolol (Cordanum, 02-115) in patients with asthma or chronic obstructive lung diseases].
    Kandt D; Hackenberger F
    Pharmazie; 1975 Oct; 30(10):681-3. PubMed ID: 697
    [No Abstract]   [Full Text] [Related]  

  • 28. Dynamic and kinetic comparison of penbutolol and propranolol in healthy volunteers [proceedings].
    Baird IM; Hill H; Ings RM; Johnson KI; McEwen J
    Br J Clin Pharmacol; 1977 Jun; 4(3):386P. PubMed ID: 20121
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.
    Cadigan PJ; London DR; Pentecost BL; Bianchetti G; Gomeni R; Kilborn JR; Morselli PL
    Br J Clin Pharmacol; 1980 Jun; 9(6):569-75. PubMed ID: 6104498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of oral befunolol on heart rate and systolic blood pressure during submaximal exercise in man.
    Miki N; Furusho Y; Itaya K; Midorikawa K; Kumagai E; Terasawa M; Ihara S; Matoba T; Toshima H
    Jpn Circ J; 1980 Oct; 44(10):783-93. PubMed ID: 6107392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrinsic sympathomimetic activity of penbutolol.
    Nyberg G; Wilhelmsson C; Vedin A
    Eur J Clin Pharmacol; 1979; 16(6):381-6. PubMed ID: 43255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man.
    Bax ND; Jones RW; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):593-6. PubMed ID: 4005101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ICI 118551 on bronchial beta-adrenoceptor function and exercise heart rate in normal man.
    Tattersfield AE; Cragg DJ
    Br J Clin Pharmacol; 1983 Dec; 16(6):587-90. PubMed ID: 6140938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dose in humans at which ICI 118,551 (a selective beta 2-adrenoceptor blocking agent) demonstrates blockade of beta 1-adrenoceptors.
    Harry JD; Norris SC; Percival GC; Young J
    Clin Pharmacol Ther; 1988 May; 43(5):492-8. PubMed ID: 2896555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.
    Warrington SJ; Turner P; Kilborn JR; Bianchetti G; Morselli PL
    Br J Clin Pharmacol; 1980 Nov; 10(5):449-52. PubMed ID: 6108127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of betaxolol on heart rate at rest and during exercise.
    Kesteloot H; Missotten A; Coupez-Lopinot R; Sluyts R
    Acta Cardiol; 1982; 37(2):117-27. PubMed ID: 6125074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62.
    Johnsson G; Jordö L; Lundborg P; Rönn O; Welin-Fogelberg I; Wikstrand J
    Eur J Clin Pharmacol; 1978 May; 13(3):163-70. PubMed ID: 27371
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on the heart rate and blood pressure responses to graded exercise.
    Jennings G; Bobik A; Korner P
    Br J Clin Pharmacol; 1981 Sep; 12(3):355-62. PubMed ID: 6117303
    [No Abstract]   [Full Text] [Related]  

  • 39. Short- and long-term studies of bucindolol in mild to moderate hypertension: efficacy, safety, and exercise responses.
    Rosendorff C; Goodman C; Coull A
    J Clin Pharmacol; 1985 Apr; 25(3):233-6. PubMed ID: 2860134
    [No Abstract]   [Full Text] [Related]  

  • 40. Pamatolol: phase I evaluation of the pharmacodynamics of a cardioselective beta adrenoceptor blocking drug.
    Carruthers SG; Hosler JP; Pentikainen P; Azarnoff DL
    Clin Pharmacol Ther; 1978 Aug; 24(2):168-74. PubMed ID: 28193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.